The procholinergic effects of the atypical antipsychotic olanzapine are independent of muscarinic autoreceptor inhibition

Mol Psychiatry. 2006 Jul;11(7):619-21. doi: 10.1038/sj.mp.4001834.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acetylcholine / metabolism*
  • Animals
  • Antipsychotic Agents / pharmacology*
  • Autoreceptors / antagonists & inhibitors*
  • Benzodiazepines / pharmacology
  • Cholinergic Agents / pharmacology*
  • Clozapine / pharmacology
  • Cognition / drug effects*
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Humans
  • Memory / drug effects
  • Mice
  • Mice, Knockout
  • Microdialysis
  • Muscarinic Antagonists / pharmacology*
  • Olanzapine
  • Receptor, Muscarinic M2 / antagonists & inhibitors*
  • Receptor, Muscarinic M2 / deficiency
  • Receptor, Muscarinic M2 / genetics
  • Receptor, Muscarinic M3 / antagonists & inhibitors*
  • Receptor, Muscarinic M3 / deficiency
  • Receptor, Muscarinic M3 / genetics
  • Receptor, Muscarinic M4 / antagonists & inhibitors*
  • Receptor, Muscarinic M4 / deficiency
  • Receptor, Muscarinic M4 / genetics
  • Scopolamine / pharmacology

Substances

  • Antipsychotic Agents
  • Autoreceptors
  • Cholinergic Agents
  • Muscarinic Antagonists
  • Receptor, Muscarinic M2
  • Receptor, Muscarinic M3
  • Receptor, Muscarinic M4
  • Benzodiazepines
  • Scopolamine
  • Clozapine
  • Olanzapine
  • Acetylcholine